Fjarde Ap Fonden Exact Sciences Corp Transaction History

Fjarde Ap Fonden

$8.34 Billion
Q1 2025

A detailed history of Fjarde Ap Fonden transactions in Exact Sciences Corp stock. As of the latest transaction made, Fjarde Ap Fonden holds 38,488 shares of EXAS stock, worth $2.16 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

38,488

Previous 46,488 17.21%

Holding current value

$2.16 Million

Previous $2.61 Million 36.22%

% of portfolio

0.02%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$43.04 - $58.51 $344,320 - $468,080	-8,000 Reduced 17.21%	38,488 $1.67 Million
Q4 2024 Feb 04, 2025	SELL	$49.33 - $71.97 $207,186 - $302,274	-4,200 Reduced 8.29%	46,488 $2.61 Million
Q3 2024 Nov 08, 2024	SELL	$42.43 - $70.83 $258,823 - $432,063	-6,100 Reduced 10.74%	50,688 $3.45 Million
Q1 2024 Apr 25, 2024	BUY	$56.27 - $73.77 $118,167 - $154,917	2,100 Added 3.84%	56,788 $3.92 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $271,676 - $348,312	4,600 Added 9.18%	54,688 $4.05 Million
Q3 2023 Oct 23, 2023	BUY	$65.94 - $99.04 $125,286 - $188,176	1,900 Added 3.94%	50,088 $3.42 Million
Q2 2023 Aug 02, 2023	BUY	$62.68 - $95.05 $231,916 - $351,685	3,700 Added 8.32%	48,188 $4.52 Million
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $250,107 - $375,081	5,300 Added 13.52%	44,488 $3.02 Million
Q4 2022 Feb 14, 2023	SELL	$30.35 - $53.15 $142,645 - $249,805	-4,700 Reduced 10.71%	39,188 $1.94 Million
Q2 2022 Aug 11, 2022	SELL	$35.61 - $76.23 $473,613 - $1.01 Million	-13,300 Reduced 23.26%	43,888 $1.73 Million
Q1 2022 May 13, 2022	SELL	$57.56 - $82.54 $172,680 - $247,620	-3,000 Reduced 4.98%	57,188 $4 Million
Q4 2021 Feb 15, 2022	BUY	$72.5 - $100.68 $252,880 - $351,171	3,488 Added 6.15%	60,188 $4.68 Million
Q2 2021 Aug 12, 2021	SELL	$93.66 - $139.27 $206,052 - $306,394	-2,200 Reduced 3.74%	56,700 $7.05 Million
Q1 2021 May 17, 2021	BUY	$116.57 - $155.01 $186,512 - $248,016	1,600 Added 2.79%	58,900 $7.76 Million
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $348,635 - $497,420	3,500 Added 6.51%	57,300 $7.59 Million
Q3 2020 Nov 13, 2020	BUY	$72.92 - $102.01 $386,476 - $540,653	5,300 Added 10.93%	53,800 $5.49 Million
Q2 2020 Aug 13, 2020	SELL	$55.75 - $92.75 $183,975 - $306,075	-3,300 Reduced 6.37%	48,500 $4.22 Million
Q1 2020 May 11, 2020	BUY	$37.9 - $104.44 $56,850 - $156,660	1,500 Added 2.98%	51,800 $3 Million
Q4 2019 Feb 10, 2020	BUY	$77.66 - $99.74 $1.04 Million - $1.34 Million	13,400 Added 36.31%	50,300 $4.65 Million
Q3 2019 Oct 31, 2019	SELL	$90.37 - $122.49 $370,517 - $502,209	-4,100 Reduced 10.0%	36,900 $3.34 Million
Q2 2019 Jul 17, 2019	BUY	$89.51 - $118.04 $3.67 Million - $4.84 Million	41,000 New	41,000 $4.84 Million

Others Institutions Holding EXAS

# of Institutions

645

Shares Held

157M

Call Options Held

1.74M

Put Options Held

1.56M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.94B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account